about
Phase II study of sunitinib malate in patients with recurrent high-grade glioma.Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients.Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center.P16.09VALUE OF FET-PET EVALUATION IN PATIENTS TREATED WITH AXITINIB.O10.07RANDOMIZED PHASE II STUDY OF AXITINIB VS. STANDARD OF CARE IN PATIENTS WITH RECURRENT GLIOBLASTOMA.Retrograde C0-C1 insertion of cervical plate electrode for chronic intractable neck and arm pain.Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma.Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab.Expression of thyroid transcription factor 1 in a chordoid glioma.Development of dural plasmacytoma after evacuation of chronic subdural hematoma: case report.Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report.Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.Mini-craniotomy as the primary surgical intervention for the treatment of chronic subdural hematoma--a retrospective analysis.Disc Fragment Herniectomy Through a Facet Joint Quadrantectomy for Extraforaminal Lumbar Herniation: Technique and Results
P50
Q33392046-7B7416CA-2487-4420-BF41-1C4AF0319BDCQ33426222-73AB20E2-1AA1-4C5E-91E7-3DFA7562575AQ33914974-E263DA00-E5FA-4D9A-BC93-B00BD1B83BD8Q38776701-9DF61F16-748C-4E62-8AB8-D8235A6CC6A4Q39084819-CBB0A923-C866-4A29-BDE1-422261DD4918Q46471645-E959472A-4C47-45D0-B637-9EB9BF06878BQ46884036-E8991397-325B-4087-8922-9CCAA12577C0Q46886954-8B845C23-8E4E-4629-B3A2-B0C5D9238CE2Q48223724-826B9D63-2A8F-4150-8DD3-91ACCA4D38CEQ48228251-020BAAD6-B9F6-4B04-A56D-D1DC5056E7BCQ48383330-C6395801-945E-431B-B7E2-030DAC2F383AQ48453710-7029EBC5-2354-45AC-B1C5-4596F988E2EDQ48522207-360BEE65-9D0D-4699-A0AB-AD9B929BB2CFQ48589675-903B94D2-182F-4083-988B-A8CE783BF688Q48599227-27B20429-5048-4674-8F29-D10A3C3CEAA6Q48865058-85AB5A12-C1B5-4655-9B31-30EC9C633D60Q51749320-EEC1845A-29A2-438D-87C9-A3A074F179C4Q57805393-2096AA95-514C-4D4B-AF50-4BFAA6DA5D8C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
J Duerinck
@ast
J Duerinck
@en
J Duerinck
@es
J Duerinck
@nl
type
label
J Duerinck
@ast
J Duerinck
@en
J Duerinck
@es
J Duerinck
@nl
prefLabel
J Duerinck
@ast
J Duerinck
@en
J Duerinck
@es
J Duerinck
@nl
P106
P1153
53986118700
P31
P496
0000-0001-9869-9806